FDA Announces Nationwide Recall of Cholesterol Medication—More Than 140,000 Bottles Affected

Greater than 140,000 bottles of a prescription ldl cholesterol treatment have been recalled on account of “failed dissolution specs,” the Meals and Drug Administration introduced earlier this month.

Ascend Laboratories of New Jersey recalled sure bottles of Atorvastatin Calcium tablets, a generic model of Lipitor, bought nationwide. The recall was introduced on Sept. 19 and given a Class II danger stage on Oct. 10.

The Class II classification signifies that the recalled treatment “could trigger momentary or medically reversible antagonistic well being penalties,” however the danger of significant well being penalties is low.

The recall impacts no less than 141,984 bottles of Atorvastatin Calcium tablets, a kind of statin used to decrease the quantity of cholesterol in an individual’s blood to stop stroke, coronary heart assault, and chest ache.

See the whole checklist of recalled medicines beneath, together with dosages, bottle sizes, and expiration dates: